TLR7/8 agonist 3

CAS No. 642473-95-8

TLR7/8 agonist 3( —— )

Catalog No. M26483 CAS No. 642473-95-8

TLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 150 In Stock
5MG 136 In Stock
10MG 226 In Stock
25MG 368 In Stock
50MG 498 In Stock
100MG 686 In Stock
200MG 923 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TLR7/8 agonist 3
  • Note
    Research use only, not for human use.
  • Brief Description
    TLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
  • Description
    TLR7/8 agonist 3 is a potent agonist of TLR7 and TLR8.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    TLR
  • Recptor
    SMARCA2| SMARCA4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    642473-95-8
  • Formula Weight
    313.405
  • Molecular Formula
    C17H23N5O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (159.54 mM)
  • SMILES
    CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wanior M, et, al. Pan-SMARCA/PB1 Bromodomain Inhibitors and Their Role in Regulating Adipogenesis. J Med Chem. 2020 Dec 10;63(23):14680-14699.
molnova catalog
related products
  • Semapimod hydrochlor...

    Semapimod (CNI 1493;AXD-455) is a tetravalent guanylhydrazone that acts as a selective inhibitor of cytokine-inducible arginine transport and NO production.

  • CU-CPT-8m

    CU-CPT-8m is an toll-like receptor 8 (TLR8) antagonist (IC50 : 67 nM).

  • ODN 1826

    ODN 1826 is a 20-mer DNA strand, a TLR9 agonist and an immunostimulant, with anti-tumor and cardioprotective effects, promoting apoptosis, and stimulating the production of NO and iNOS. ODN 1826 is a CpG DNA mimetic that can be used as an adjuvant for synthetic vaccines.